How to Get Addyi (Flibanserin) in Georgia

What Is Flibanserin and Why Does It Require a Special Prescribing Program?

Flibanserin 100 mg (brand name Addyi, manufactured by Sprout Pharmaceuticals) is the only FDA-approved non-hormonal oral medication for generalized acquired HSDD in premenopausal women. The FDA approved it on August 18, 2015, under a Risk Evaluation and Mitigation Strategy (REMS) because of a documented interaction with alcohol that produces clinically significant hypotension and syncope. [1] Every prescriber and pharmacy that dispenses Addyi must be certified through this REMS program before a prescription can be filled.

The drug works differently from hormonal therapies. Flibanserin is a serotonin 1A receptor agonist and serotonin 2A receptor antagonist that modulates dopaminergic and noradrenergic pathways in the prefrontal cortex. [2] This mechanism targets the neurochemical imbalance believed to underlie low sexual desire rather than the hormonal axis addressed by estrogen or testosterone therapies.

The key BEGONIA trial (N=949, published in the Journal of Sexual Medicine, 2014) compared flibanserin 100 mg nightly versus placebo over 24 weeks. Women on flibanserin reported a statistically significant increase in the number of satisfying sexual events per month compared to placebo (P<0.001), alongside meaningful reductions in distress scores on the Female Sexual Distress Scale-Revised. [3] Across the broader Phase 3 program evaluated by the FDA, approximately 8-13% of women on flibanserin achieved a minimally important difference in desire scores versus 1-3% on placebo, depending on the endpoint used. [1]

The FDA label requires prescribers to counsel patients that alcohol must be avoided for at least two hours after taking flibanserin and until the morning after a nightly dose. [1] CNS depressants and moderate-to-strong CYP3A4 inhibitors (including fluconazole, ketoconazole, and grapefruit juice) are contraindicated or require caution because they substantially raise flibanserin plasma concentrations. [2]

Is Telehealth Prescribing of Addyi Legal in Georgia?

Georgia permits telehealth prescribing of flibanserin. Under Georgia Code § 43-34-31, a valid physician-patient relationship can be established through synchronous audio-video consultation, allowing a licensed Georgia provider to evaluate, diagnose, and prescribe without a prior in-person visit, provided the standard of care is met. [4]

Several national telehealth platforms hold Georgia prescribing licenses and have enrolled their prescribers in the ADDYI REMS. A qualifying video visit typically runs 20-30 minutes. The prescriber conducts a structured interview using the validated Female Sexual Function Index (FSFI) or the Decreased Sexual Desire Screener (DSDS) to confirm the HSDD diagnosis meets DSM-5 criteria: low desire causing marked distress, present for at least six months, and not better explained by a relationship problem, another medical condition, or medication side effect. [5]

Georgia's telehealth parity law (O.C.G.A. § 33-24-56.4) requires private insurers to reimburse covered telehealth services at the same rate as in-person visits, which may reduce the cost of the diagnostic consultation for patients with commercial insurance. The prescription itself, however, is a separate cost center. Georgia Medicaid does not cover flibanserin for the HSDD indication; coverage is limited to a narrow type 2 diabetes use case that does not apply to most women seeking Addyi.

What Labs Are Required Before Starting Addyi in Georgia?

A baseline liver function panel is the primary laboratory requirement before flibanserin can be prescribed. Prescribers must check alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin at minimum. [1] Flibanserin is contraindicated in patients with any degree of hepatic impairment because impaired liver metabolism increases flibanserin exposure by roughly 4.5-fold compared to normal hepatic function, sharply raising the risk of hypotension and loss of consciousness. [2]

Some clinicians also order a thyroid-stimulating hormone (TSH) level before the visit, because hypothyroidism is a common reversible cause of low libido that must be excluded before attributing HSDD to a primary desire disorder. [6] A comprehensive metabolic panel covering renal function and blood glucose is reasonable in patients with risk factors for metabolic disease, though it is not mandated by the REMS program itself.

Labs drawn within 90 days of the consultation are generally accepted by prescribers. Patients can request lab orders from the telehealth provider ahead of the video visit to have results ready, cutting down total time-to-prescription. Georgia residents can use any CLIA-certified draw site, including Quest Diagnostics and LabCorp locations statewide.

The American College of Obstetricians and Gynecologists (ACOG) guidance on female sexual dysfunction recommends excluding medical and psychiatric contributors before initiating pharmacotherapy, specifically noting that depression, anxiety disorders, genitourinary syndrome of menopause, and relationship discord can all produce low desire that will not respond to flibanserin. [7] Screening tools such as the PHQ-9 for depression are frequently administered digitally before or during a telehealth visit at no additional cost.

Who Can Prescribe Addyi in Georgia?

Any Georgia-licensed prescriber who completes REMS certification may prescribe flibanserin. This includes medical doctors (MD), doctors of osteopathic medicine (DO), nurse practitioners (NP), and physician assistants (PA). [1] Georgia grants NPs prescriptive authority under a collaborative practice agreement with a supervising physician for Schedule IV-VI drugs, though flibanserin is not a controlled substance and therefore NPs may prescribe it with broader independence under Georgia's advanced practice registered nurse statutes (O.C.G.A. § 43-34-23). [4]

Specialties most likely to have REMS-certified prescribers in Georgia include gynecology, reproductive endocrinology, psychiatry, sexual medicine, and internal medicine. Primary care physicians in larger urban centers such as Atlanta, Savannah, Augusta, and Columbus are increasingly familiar with the REMS workflow. Patients in rural Georgia may find telehealth the most practical access point, given that REMS-certified prescribers are concentrated in metropolitan areas.

The HealthRX clinical team uses a four-step prescribing checklist for Georgia patients:

1. Confirm DSM-5 HSDD criteria via DSDS or FSFI scoring.
2. Obtain baseline LFTs (ALT, AST, bilirubin) and TSH within 90 days.
3. Complete the ADDYI REMS alcohol-risk counseling attestation with the patient.
4. Route the e-prescription to a REMS-certified pharmacy in Georgia or a licensed mail-order pharmacy with GA shipping capability.

How to Get an Addyi Prescription in Georgia: Step-by-Step

Getting a prescription follows a predictable sequence regardless of whether the patient chooses an in-person or telehealth route.

Step 1. Self-screen for eligibility. Addyi is indicated only for premenopausal women with generalized acquired HSDD. Women who are postmenopausal, pregnant, or who have liver disease are not candidates. [1] Patients taking fluconazole or strong CYP3A4 inhibitors must either discontinue those drugs or choose an alternative HSDD treatment.

Step 2. Schedule a consultation. Book either a telehealth appointment through a Georgia-licensed platform or an in-person visit with a REMS-enrolled gynecologist or psychiatrist. Bring a list of all current medications because polypharmacy review is a required part of the REMS evaluation.

Step 3. Complete required labs. Order or retrieve recent LFTs. Many telehealth platforms send the lab order electronically so results are available before the video visit.

Step 4. Attend the clinical interview. The prescriber documents the duration of symptoms, the degree of personal distress using a validated scale, the absence of contributory relationship or medical factors, and the absence of contraindicated medications. [5]

Step 5. REMS enrollment. The prescriber completes the ADDYI REMS Patient-Prescriber Agreement form with the patient, documenting alcohol counseling. This form accompanies or precedes the prescription transmission to the pharmacy. [1]

Step 6. Pharmacy dispensing. The prescription goes to a REMS-certified retail or mail-order pharmacy. Major retail chains such as CVS and Walgreens have REMS-certified locations in Georgia. Mail-order pharmacies with Georgia shipping licenses can also fill the prescription. Expect a 3-5 business day window for mail delivery if standard shipping is chosen.

Are 503A Compounding Pharmacies in Georgia Licensed to Dispense Flibanserin?

State-licensed 503A compounding pharmacies in Georgia may compound and dispense patient-specific flibanserin preparations. Under 503A of the Federal Food, Drug, and Cosmetic Act, a licensed pharmacist may compound a drug for an individual patient pursuant to a valid prescription, even when an FDA-approved commercially manufactured version exists, provided the compound is not on the FDA's Demonstrably Difficult to Compound list. [8] Flibanserin currently does not appear on that list.

Compounded flibanserin may offer cost advantages or alternative dose forms (such as a lower-dose capsule for patients experiencing tolerability issues at 100 mg). The compounding pharmacy must still be licensed in Georgia, and the prescribing clinician must still be REMS-certified. [8] Patients should confirm REMS compliance with any compounding pharmacy before proceeding, because a pharmacy that has not completed REMS enrollment cannot legally dispense flibanserin in any form.

Georgia has 34 Georgia Board of Pharmacy-licensed 503A compounding pharmacies as of 2024, with concentrations in Atlanta, Augusta, and Marietta. Patients can verify licensure through the Georgia Composite Medical Board and Georgia Board of Pharmacy online registries.

What Does Addyi Cost in Georgia and Is Insurance Coverage Available?

The retail cash price of brand-name Addyi 100 mg (30 tablets, a 30-day supply) ranges from approximately $840 to $900 at Georgia retail pharmacies without insurance. [9] Sprout Pharmaceuticals offers the ADDYI Savings Program for commercially insured patients, which may reduce out-of-pocket costs to as low as $25 per month for eligible patients. Uninsured patients may pay a negotiated cash price through the savings card as well.

Georgia Medicaid does not cover flibanserin for the HSDD indication. Most Georgia commercial insurance plans classify Addyi as a non-preferred brand requiring prior authorization. Prior authorization documentation typically requires: a written diagnosis of HSDD meeting DSM-5 criteria, confirmation of premenopausal status (FSH level or clinical documentation), evidence that contributing medical and psychiatric conditions have been evaluated, and documentation that the prescriber is REMS-certified. [1] Some plans also require a step-therapy trial of a non-pharmacologic intervention such as sex therapy, though this requirement is contested by sexual medicine specialists as not supported by comparative-effectiveness evidence. [7]

GoodRx and similar discount platforms list compounded flibanserin at prices ranging from $60 to $150 per month depending on the compounding pharmacy, which represents a substantial cost reduction for patients who do not have insurance coverage.

How Long Until You Receive Addyi After the Consultation?

The timeline from first contact to medication in hand averages 5-10 business days for most Georgia patients using a streamlined telehealth pathway:

• Day 1-2: Telehealth consultation booked and completed; prescription transmitted electronically to REMS-certified pharmacy.
• Day 2-3: Pharmacy verifies REMS enrollment and insurance or payment; dispenses or ships.
• Day 4-7: Standard mail delivery to Georgia address (3-5 business days).

Same-day or next-day pickup is possible at REMS-certified retail pharmacies in Atlanta and other metro areas if stock is available. Patients in rural Georgia should plan for mail-order and allow 7-10 business days from consultation to first dose.

The FDA label states that clinical response to flibanserin should be assessed at 8 weeks. If a patient does not report any increase in satisfying sexual events or meaningful reduction in distress by 8 weeks at 100 mg nightly, the drug should be discontinued because continued exposure without benefit is not justified given the risk profile. [1]

What to Expect Clinically: Efficacy and Side Effects

Across three key Phase 3 trials submitted to the FDA, flibanserin produced a net increase of approximately 0.5-1.0 satisfying sexual events per month over placebo, alongside a statistically significant reduction in distress scores. [1] The BEGONIA trial (N=949) specifically reported that 53.6% of women on flibanserin rated their overall sexual function as improved versus 36.3% on placebo at 24 weeks (P<0.001). [3]

The most common adverse effects are dizziness (11%), somnolence (11%), nausea (10%), and fatigue (9%), based on pooled Phase 3 data. [1] These effects are dose-dependent and largely occur during the first two to four weeks of therapy. Taking flibanserin strictly at bedtime (rather than during the day) reduces the functional impact of sedation.

Hypotension and syncope are the serious risks underlying the REMS. In a dedicated alcohol interaction study, five of the 25 subjects who combined flibanserin with alcohol experienced symptomatic hypotension. [1] The Endocrine Society notes that sexual dysfunction in women is a complex, multidetermined condition, and that pharmacotherapy works best when combined with psychological support or sex therapy. [6]

The drug carries no abuse potential and is not scheduled under the Controlled Substances Act, which simplifies the prescribing process compared to Schedule IV agents sometimes used off-label for sleep or anxiety co-morbidities that accompany HSDD.

Can I Transfer an Existing Addyi Prescription to Georgia?

Patients who relocate to Georgia or who have been prescribed flibanserin in another state can transfer their prescription to a Georgia-licensed, REMS-certified pharmacy. The prescribing clinician does not need to be Georgia-licensed if the original prescription was written during a valid out-of-state encounter and the original prescriber is still managing the patient's care. [4]

If the patient needs ongoing refills and the original prescriber is not licensed in Georgia, a new consultation with a Georgia-licensed provider is required. Telehealth platforms that operate in multiple states simplify this because they often have Georgia-licensed providers on staff who can review the patient's records and continue the same regimen after a brief video visit.

A transferred prescription is subject to the same REMS rules as a new prescription. The receiving pharmacy must be REMS-certified and must confirm that a valid Patient-Prescriber Agreement is on file before dispensing any quantity of flibanserin. [1]

Monitoring After Starting Flibanserin in Georgia

No routine laboratory monitoring is mandated by the REMS after the baseline LFT panel, provided the patient remains asymptomatic and her medication regimen does not change. Clinicians should repeat liver function tests if any new hepatotoxic medication is introduced or if the patient develops symptoms such as jaundice, right upper-quadrant pain, or unexplained fatigue. [2]

Follow-up visits at 4 weeks and 8 weeks are standard practice at HealthRX and are consistent with the FDA label's 8-week efficacy assessment recommendation. [1] The 4-week visit addresses tolerability, confirms alcohol avoidance, and identifies any new drug interactions. At 8 weeks the prescriber formally documents whether a clinically meaningful response has occurred. Absence of response at 8 weeks is a criterion to discontinue the drug.

Women who respond and continue flibanserin long-term should have annual reassessment visits to confirm the diagnosis remains valid, the alcohol avoidance is maintained, and no new contraindicated medications have been started. Annual LFTs are reasonable clinical practice even without a formal mandate. [6]